Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03FLT
|
||||
Former ID |
DIB005141
|
||||
Drug Name |
CP-331684
|
||||
Synonyms |
2-[4-[2-[2(R)-(6-Amino-3-pyridinyl)-2-hydroxyethylamino]ethoxy]phenyl]acetic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Phase 2 | [547126] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H21N3O4
|
||||
Canonical SMILES |
C1=CC(=CC=C1CC(=O)O)OCCNCC(C2=CN=C(C=C2)N)O
|
||||
InChI |
1S/C17H21N3O4/c18-16-6-3-13(10-20-16)15(21)11-19-7-8-24-14-4-1-12(2-5-14)9-17(22)23/h1-6,10,15,19,21H,7-9,11H2,(H2,18,20)(H,22,23)/t15-/m0/s1
|
||||
InChIKey |
GZJZZQHTBTUBEL-HNNXBMFYSA-N
|
||||
CAS Number |
CAS 207922-70-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Beta-3 adrenergic receptor | Target Info | Agonist | [551914] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.